Latest industry news and developments
The U.S. FDA has introduced daily updates on adverse event data, marking a major shift toward real-time safety monitoring. This move forces industry, clinicians, and patients to react faster than ever before. Could Europe be the next to follow this model?
The MDCG has updated guidance on the use of Master UDI-DI for contact lenses, one of the most widely used medical devices worldwide. The new rules streamline identification and reporting while strengthening patient safety. Learn how to assign UDI correctly and avoid common mistakes in EUDAMED.
This new Team-NB Position Paper on Software Qualification cuts through the ambiguity of software qualification under the IVDR, offering actionable criteria and updated examples. A must-read for IVD software developers and regulatory professionals navigating borderline classifications.
The MDCG outlines in the MDCG 2025-7 Position Paperphased timelines for implementing the Master UDI-DI for highly individualized optical devices, including contact lenses and spectacles. Manufacturers are encouraged to act early to benefit from EUDAMED registration capabilities and prepare for future vigilance obligations.
The long-awaited Regulation (EU) 2025/1234 now allows manufacturers to provide e-IFUs for all devices intended for professional use. This marks a significant step towards digital documentation in the EU. The article explains eligibility, technical requirements, and the legal framework behind this change.
This update revisits how software should be qualified and classified under MDR, with specific emphasis on Rule 11. The article compares the 2019 and 2025 versions and highlights what manufacturers must now do. It also discusses the broader implications for notified body reviews.
New MDCG documents clarify the roles of platform operators under MDR/IVDR and the AI Act. As software becomes more complex, responsibilities shift to include post-market monitoring and algorithm accountability. Essential reading for developers, distributors and notified bodies.
The European Commission has published updated templates for MIR and FSCA forms, standardizing how medical device incidents are reported. These documents align with Eudamed requirements and evolving expectations from regulators and manufacturers, enhancing transparency and interoperability across the EU.
Switzerland has adopted regulatory changes enabling temporary authorization for high-risk medical devices even without MDR or Swiss approval. The law allows imports from trusted markets (EU, USA, Canada) to address critical supply gaps.
